Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2016, Vol. 2 Issue (1): 903-905    DOI: 10.19485/j.cnki.issn1007-0931.2017.09.010
综述     
女性恶性肿瘤患者生育力保存研究进展
段翠翠, 综述, 徐键, 审校
浙江大学医学院附属妇产科医院,浙江 杭州 310000
 全文: PDF(396 KB)   HTML
摘要: 随着恶性肿瘤患者生存率不断提高,不孕症等放化疗手术引起的不良反应受到越来越多的重视,女性恶性肿瘤患者对生育力保存的要求也越来越高。肿瘤医学与生殖医学的进步与合作极大地促进了生育力保存技术的发展。本文就恶性肿瘤治疗对生育力的影响及女性恶性肿瘤患者生育力保存技术进展进行综述。
关键词: 不孕恶性肿瘤生育力保存    
收稿日期: 2017-04-25 出版日期: 2018-01-16
ZTFLH:  R173  
基金资助: 生殖健康状况评估及关键技术研究(2012BAI32B00)
通讯作者: 徐键,E-mail:xuj@zju.edu.cn   
作者简介: 段翠翠,硕士,医师,主要从事妇产科临床工作
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
段翠翠
综述
徐键
审校

引用本文:

段翠翠, 综述, 徐键, 审校. 女性恶性肿瘤患者生育力保存研究进展[J]. 中国生物工程杂志, 2016, 2(1): 903-905.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/Y2016/V2/I1/903

[1] CHUNG K,DONNEZ J,GINSBURG E,et al. Emergency IVF versus ovarian tissue cryopreservation:decision making in fertility preservation for female cancer patients[J]. Fertil Steril,2013,99(6):1534-1542.
[2] JONES G L,HUGHES J,MAHMOODI N,et al. Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer:the Cancer,Fertility and Me research protocol[J]. BMJ Open,2017,7(3):e013219.
[3] ROMAO R L,LORENZO A J. Fertility preservation options for children and adolescents with cancer[J]. Journal de l'Association des urologues du Canada,2017,11(Suppl1):S97-S102.
[4] BROWN J R,MODELL E,OBASAJU M,et al. Natural cycle in-vitro fertilization with embryo cryopreservation prior to chemotherapy for carcinoma of the breast[J]. Hum Reprod,1996,11(1):197-199.
[5] AJALA T,RAFI J,LARSEN-DISNEY P,et al. Fertility preservation for cancer patients:a review[J]. Obstet Gynecol Int,2010(2010):160386.
[6] WALLACE W H,ANDERSON R A,IRVINE D S. Fertility preservation for young patients with cancer:who is at risk and what can be offered[J]. Lancet Oncol,2005,6(4):209-218.
[7] SPEISER D,MANGLER M,KÖHLER C,et al. Fertility outcome after radical vaginal trachelectomy:a prospective study of 212 patients[J]. Int J Gynecol Cancer,2011,21(9):1635- 1639.
[8] GUNDERSON C C,FADER A N,CARSON K A,et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma:a systematic review[J]. Gynecol Oncol,2012,125(2):477-482.
[9] HAREL S,FERMÉ C,POIROT C. Management of fertility in patients treated for Hodgkin's lymphoma[J]. Haematologica,2011,96(11):1692-1699.
[10] BEDOSCHI G,OKTAY K. Current approach to fertility preservation by embryo cryopreservation[J]. Fertil Steril,2013,99(6):1496-1502.
[11] 李微,张娜. 女性生育力保存技术的研究进展[J]. 国际生殖健康/计划生育杂志,2016,35(5):409-412.
[12] 郭红燕,李圆. 肿瘤生殖学研究进展对卵巢恶性肿瘤治疗的影响[J]. 实用妇产科杂志,2016,32(11):813-815.
[13] TURAN V,BEDOSCHI G,MOY F,et al. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients[J]. Fertil Steril,2013,100(6):1681- 1685.
[14] KIM S S,DONNEZ J,BARRI P,et al. Recommendations for fertility preservation in patients with lymphoma,leukemia,and breast cancer[J]. J Assist Reprod Genet,2012,29(6):465-468.
[15] OKTAY K,TÜRKCÜOGLU I,RODRIGUEZ-WALLBERG K A. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation[J]. Reprod Biomed Online,2010,20(6):783-788.
[16] REVEL A,REVEL-VILK S. Fertility preservation in young cancer patients[J]. J Hum Reprod Sci,2010,3(1):2-7.
[17] COCCIA P F,ALTMAN J,BHATIA S,et al. Adolescent and young adult oncology. Clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw,2012,10(9):1112-1150.
[18] VADAPARAMPIL S T,HUTCHINS N M,QUINN G P. Reproductive health in the adolescent and young adult cancer patient:an innovative training program for oncology nurses[J]. J Cancer Educ,2013,28(1):197-208.
[19] 马悦,张士慧,陆,等. 女性癌症患者生育力保存方法的研究综述[J]. 解放军医学院学报,2016,37(11):1190-1192,1207.
[20] PRASATH E B,CHAN M L,WONG W H,et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient[J]. Human Reproduction,2013,29(2):276-278.
[21] 姚桂东,孙莹璞. 卵巢组织冷冻复苏及移植[J]. 实用妇产科杂志,2016,32(4):250-253.
[22] 张聪,张娜. 女性肿瘤患者生育力保存的研究现状[J]. 国际生殖健康/计划生育杂志,2016,35(5):413-417.
[23] DONNEZ J,DOLMANS M M,DEMYLLE D,et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue[J]. Lancet,2004,364(9443):1405-1410.
[24] 颜磊,陈子江. 卵巢恶性肿瘤治疗后的生育和助孕策略[J]. 实用妇产科杂志,2016,32(11):809-811.
[25] HERRAIZ S,NOVELLA-MAESTRE E,RODRÍGUEZ B,et al. Improving ovarian tissue cryopreservation for oncologic patients:slow freezing versus vitrification,effect of different procedures and devices[J]. Fertil Steril,2014,101(3):775-784.
[26] AMORIM C A,DAVID A,VAN LANGENDONCKT A,et al. Vitrification of human ovarian tissue:effect of different solutions and procedures[J]. Fertility and Sterility,2011,95(3):1094-1097.
[27] IMBERT R,MOFFA F,TSEPELIDIS S,et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility:a 12-year retrospective analysis[J]. Hum Reprod,2014,29(9):1931-1940.
[28] MAFFEI S,PENNAROSSA G,BREVINI T A,et al. Beneficial effect of directional freezing on in vitro viability of cryopreserved sheep whole ovaries and ovarian cortical slices[J]. Hum Reprod,2014,29(1):114-124.
[29] 范东青,张璨. 卵巢冷冻移植的发展历程及研究现状[J]. 国际生殖健康/计划生育杂志,2016,35(5): 405-408.
[1] 王虹 裘宇容 王钧 王纯直 梁镇兴 王珊珊. 促血管生成素-2检测试剂盒的研制和临床研究[J]. 中国生物工程杂志, 2010, 30(01): 29-34.
[2] 吴晓岩, 张兰萍, 刘翠晴, 张玲玲. 碱性磷酸酶同工酶研究进展与应用[J]. 中国生物工程杂志, 1999, 19(3): 18-21.
[3] 顾健人. 基因治疗的昨天、今天与明天[J]. 中国生物工程杂志, 1997, 17(6): 21-25.
[4] 陈竺. 早幼粒白血病相关基因的结构和功能研究[J]. 中国生物工程杂志, 1995, 15(3): 8-9.
[5] 王彩福, 张健诚, 姚宁, 苏盛. LAK细胞实验室及临床研究的进展[J]. 中国生物工程杂志, 1991, 11(6): 19-22.
[6] 罗明典. 干扰素基因工程在我国的发展[J]. 中国生物工程杂志, 1985, 5(4): 68-69.